- Home
- VNT vs CORT Comparison
VNT vs CORT Comparison
Compare VNT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNT
- CORT
- Stock Information
- Founded
- VNT 2019
- CORT 1998
- Country
- VNT United States
- CORT United States
- Employees
- VNT N/A
- CORT N/A
- Industry
- VNT Industrial Machinery/Components
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- VNT Industrials
- CORT Health Care
- Exchange
- VNT Nasdaq
- CORT Nasdaq
- Market Cap
- VNT 5.9B
- CORT 5.9B
- IPO Year
- VNT N/A
- CORT N/A
- Fundamental
- Price
- VNT $37.11
- CORT $52.17
- Analyst Decision
- VNT Buy
- CORT Strong Buy
- Analyst Count
- VNT 9
- CORT 4
- Target Price
- VNT $43.14
- CORT $75.25
- AVG Volume (30 Days)
- VNT 920.3K
- CORT 848.2K
- Earning Date
- VNT 02-13-2025
- CORT 02-13-2025
- Dividend Yield
- VNT 0.27%
- CORT N/A
- EPS Growth
- VNT 21.70
- CORT 57.97
- EPS
- VNT 2.62
- CORT 1.26
- Revenue
- VNT $2,991,200,000.00
- CORT $628,555,000.00
- Revenue This Year
- VNT N/A
- CORT $46.29
- Revenue Next Year
- VNT $3.54
- CORT $17.09
- P/E Ratio
- VNT $14.16
- CORT $41.38
- Revenue Growth
- VNT N/A
- CORT 39.67
- 52 Week Low
- VNT $31.22
- CORT $20.84
- 52 Week High
- VNT $45.62
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- VNT 42.34
- CORT 37.38
- Support Level
- VNT $35.79
- CORT $49.51
- Resistance Level
- VNT $39.86
- CORT $60.90
- Average True Range (ATR)
- VNT 0.86
- CORT 2.60
- MACD
- VNT -0.37
- CORT -1.16
- Stochastic Oscillator
- VNT 28.57
- CORT 13.83
About VNT Vontier Corporation
Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3.1 billion in sales in 2023.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.